Financials

News Ideas Technicals

CLBIO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CORLINE BIOMEDICAL AB operating, investing, and financing activities

CLBIO free cash flow for Q1 24 is 2.3 M SEK. For 2023, CLBIO free cash flow was 754 k SEK and operating cash flow was 886 k SEK.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: SEK

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—